All In Biotech

Free tool

FAERS Monitor: Cotellic

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 206192 or its brand name (Cotellic, Cobimetinib Fumarate). Reports on generic versions are filed under their own applications.

Reports

4,436

Serious

3,673

83% of reports

Hospitalization

2,006

Death reported

588

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use482
  • diarrhoea446
  • rash402
  • pyrexia368
  • death253
  • nausea235
  • fatigue221
  • vomiting185
  • no adverse event183
  • acute kidney injury139
  • asthenia134
  • photosensitivity reaction133
  • rash maculo-papular125
  • anaemia122
  • drug reaction with eosinophilia and systemic symptoms120

Reports by year received

View as table
YearReports
20111
20121
201316
201426
201586
2016455
2017583
2018706
2019556
2020370
2021362
2022342
2023239
2024368
2025194
2026131

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,723 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
photosensitivity reactionSignal13338.532.54,785
rash maculo-papularSignal12526.822.53,063
drug reaction with eosinophilia and systemic symptomsSignal12022.218.62,401
pyrexiaSignal3685.04.61,209
no adverse eventSignal1834.84.2550
rashSignal4024.44.01,065
acute kidney injurySignal1394.33.7352
diarrhoeaSignal4463.33.0725
anaemiaSignal1223.02.5166
off label useSignal4822.62.4498
vomiting1851.91.675
asthenia1341.71.438
nausea2351.41.228
death2531.41.229
fatigue2211.31.220

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.